Guardant Health to Participate in Upcoming August Investor Conferences

Rhea-AI Summary

Guardant Health (Nasdaq: GH) will participate in two upcoming virtual investor conferences. The UBS Genomics 2.0 and Medtech Innovations Summit fireside chat is scheduled for August 11 at 9 a.m. PT / 12 p.m. ET. The Canaccord Virtual Growth Conference fireside chat will follow on August 13 at 1 p.m. PT / 4 p.m. ET. Interested parties can access the live and archived webcasts on the company's website. Guardant Health specializes in precision oncology and offers advanced blood tests that improve patient outcomes and reduce healthcare costs.

REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences.

• UBS Genomics 2.0 and Medtech Innovations Summit
  Fireside Chat on Tuesday, August 11th at 9 a.m. Pacific Time / 12 p.m. Eastern Time
  
  
• Canaccord Virtual Growth Conference
  Fireside Chat on Thursday, August 13th at 1 p.m. Pacific Time / 4 p.m. Eastern Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360^® and GuardantOMNI^® tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com

FAQ

What are the dates and times for the Guardant Health virtual conferences in August 2020?

Guardant Health will participate in two virtual conferences: UBS Genomics 2.0 on August 11 at 9 a.m. PT / 12 p.m. ET and Canaccord Virtual Growth Conference on August 13 at 1 p.m. PT / 4 p.m. ET.

How can I access the presentations from Guardant Health's virtual conferences?

The presentations can be accessed live and archived on the 'Investors' section of Guardant Health's website.

What is Guardant Health known for?

Guardant Health is a leading precision oncology company focused on using blood tests and data analytics to help conquer cancer globally.

What is the significance of the Guardant360 and GuardantOMNI tests?

Guardant360 and GuardantOMNI are liquid biopsy-based tests for advanced stage cancer patients, aimed at improving clinical outcomes.

What is the LUNAR program by Guardant Health?

The LUNAR program focuses on addressing the needs of early stage cancer patients and those at higher risk for developing cancer.